For example, upregulated signaling pathways are activated in mouse models of SNF5 loss and rhabdoid patient samples [34, 35], while invasion/motility genes are also increased in patient-derived xenografts [36], suggesting the possibility that altered AP-1 function may be involved driving the rhabdoid tumor state. This evidence concerns the gene FOS and neoplasm.